Long term (current) use of immunomodulators and immunosuppressants
Notes: Long term (current) use of apremilast ; Long term (current) use of immunomodulatory imide drug ; Long term (current) use of lenalidomide ; Long term (current) use of pomalidomide ; Long term (current) use of adalimumab ; Long term (current) use of etanercept ; Long term (current) use of infliximab ; Long term (current) use of monoclonal antibodies ; Long term (current) use of cyclosporine ; Long term (current) use of tacrolimus ; Long term (current) use of tofacitinib ; Long term (current) use of sirolimus ; Long term (current) use of azathioprine ; Long term (current) use omycophenolate ; Long term (current) use of purine synthesis (IMDH) inhibitors ; Long term (current) use of chlorambucil ; Long term (current) use of cisplatin ; Long term (current) use of cyclophosphamide ; Long term (current) use of 5-fluorouracil ; Long term (current) use of 6-mercaptopurine ; Long term (current) use of cytarabine ; Long term (current) use of methotrexate ; Long term (current) use of bleomycin ; Long term (current) use of doxorubicin ; Long term (current) use of mitomycin C ; Long term (current) use of paclitaxel ; Long term (current) use of plant alkaloids ; Long term (current) use of vinblastine ; Long term (current) use of vincristine ; Long term (current) use of etoposide ; Long term (current) use of irinotecan ; Long term (current) use of topotecan ; Long term (current) use of hydroxyurea ; long term (current) use of steroids (Z79.5-) ; long term (current) use of agents affecting estrogen receptors and estrogen levels (Z79.81-)
- 2535 แพทยศาสตร์บัณฑิต เกียรตินิยมอันดับ 1
- 2539 วุฒิบัตร อายุรศาสตร์
- อายุรแพทย์ @ pattayadoctor.com , Thaihealth.net
- อายุรแพทย์ Jomtien hospital